Results 51 to 60 of about 43,879 (232)

Immunogenicity, Safety, and Clinical Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Spondyloarthritis (Preliminary Data)

Антибиотики и Химиотерапия, 2022
Background. Immunosuppressive drugs are widely used for the treatment of patients with spondyloarthritis (SpA) to effectively control the activity of the disease.
M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. V. Cherkasova, Zh. G. Verizhnikova, T. V. Korotaeva   +5 more
doaj   +1 more source

Real‐World Trends in Prenatal Antirheumatic Drug Utilization in Ontario, Canada: A Cross‐Sectional Time‐Series Analysis

Arthritis Care &Research, EarlyView.
Objective This study aimed to describe real‐world trends in preconception and prenatal use of antirheumatic drugs among pregnant individuals with rheumatic diseases in Ontario, Canada. Methods We conducted a time‐series analysis using repeated cross‐sectional data to examine annual patterns of disease‐modifying antirheumatic drug (DMARD) use among ...
Shenthuraan Tharmarajah, Swaleh Hussain, Sara J. T. Guilcher, Lisa M. McCarthy, Dharini Mahendira, Howard Berger, Mina Tadrous   +6 more
wiley   +1 more source

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Scientific Reports
To compare the demographic, clinical, and laboratory characteristics, disease onset, and clinical features of radiographic axial Spondyloarthritis (r-axSpA) and non-radiographic axial Spondyloarthritis (nr-axSpA) patients.
John Londono, Cesar Pacheco-Tena, Ana Maria Santos, Mario Humberto Cardiel, Gustavo Rodríguez-Salas, Igor Rueda, Sofía Arias-Correal, Cristian Mesa, Mantilla Marta Juliana, Juan Camilo Santacruz, Juan Camilo Rueda, Gilberto Vargas-Alarcón, Rubén Burgos-Vargas   +12 more
doaj   +1 more source

Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology

Научно-практическая ревматология, 2022
Despite great advances in the diagnosis and treatment of Immune-mediated inflammatory diseases (IMIDs), which have led to a significant improvement in the prognosis in many patients, the central medical problems of this pathology – restoring the quality ...
E. L. Nasonov, T. V. Korotaeva
doaj   +1 more source

Women and spondyloarthritis

Reumatismo
Spondyloarthritis is an umbrella term for a heterogeneous group of chronic inflammatory diseases affecting the spine and/or peripheral joints, often associated with extra-articular manifestations, such as psoriasis, uveitis, and inflammatory bowel disease...
Ramonda, R, Oliviero, F
openaire   +4 more sources

Axial Spondyloarthritis: An Evolving Concept [PDF]

, 2015
Axial spondyloarthritis (AxSpA) is the prototype of a family of inter-related yet heterogeneous diseases sharing common clinical and genetic manifestations: the spondyloarthritides (SpAs).
Nelly Ziadé
core  

Original paper Cytokine profiles in axial spondyloarthritis

, 2015
Objectives: Current studies concentrate on the cytokine network and its role in the pathogenesis of spondyloarthritis (SpA). In this study, we analyzed whether the serum cytokine profile (interleukins: IL-10, IL-11, IL-12, IL-15, IL-17, IL-23 and IL-33)
Marta Madej, Piotr Wiland, Beata Nowak, Arkadiusz Chlebicki, Lucyna Korman, Łukasz Lubiński, Jerzy Świerkot, Renata Sokolik, Patryk Woytala   +8 more
core   +1 more source

Comorbid infections in patients with spondyloarthritis who received modern antirheumatic therapy (preliminary data)

Научно-практическая ревматология, 2022
Actuality. Data on the prevalence of comorbid infections (CI) in patients with spondyloarthritis (SpA) are few. Risk factors for CI has not been sufficiently studied.Objective.
M. M. Baranova, N. V. Muravyeva, B. S. Belov, S. I. Glukhova, T. V. Korotaeva   +4 more
doaj   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source

Elevating the Standard of Care for Patients with Axial Spondyloarthritis: ‘Calls to Action’ from Rheumacensus, a Multistakeholder Pan-European Initiative

Rheumatology and Therapy
Introduction Several barriers to optimal care in axial spondyloarthritis (axSpA) exist, which is detrimental to patient outcomes. The Rheumacensus programme aimed to identify how the standard of care (SoC) and treatment ambition for patients with axSpA ...
Andri Phoka, Bart J. F. van den Bemt, Ennio Lubrano, Inderjit Singh, Cristina Fernández-Carballido, Detlev Parow, Dale Webb, Fabienne Lacombe, Laura Harrington, Xenofon Baraliakos   +9 more
doaj   +1 more source